Neurocardiogenic syncope

New England Journal of Medicine

Volumn 352, Issue 10, 2005, Pages

  Grubb, Blair P ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; ENALAPRIL; EPHEDRINE; ESCITALOPRAM; FLUDROCORTISONE; METOPROLOL; MIDODRINE; PAROXETINE; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; VASOCONSTRICTOR AGENT;

ADULT; AGITATION; BLOATING; BRADYCARDIA; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONFUSION; CONSCIOUSNESS; DIARRHEA; DIZZINESS; FACE INJURY; FALLING; FATIGUE; FEMALE; HEADACHE; HEART PACING; HUMAN; HYPERTENSION; HYPOKALEMIA; INCONTINENCE; INSOMNIA; NAUSEA; NEUROCARDIOGENIC SYNCOPE; NURSE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; REVIEW; SALT INTAKE; SIDE EFFECT; STANDING; SYNCOPE; TILT TABLE TEST; ARTIFICIAL HEART PACEMAKER; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; PRACTICE GUIDELINE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FLUDROCORTISONE; HUMANS; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES; SEROTONIN UPTAKE INHIBITORS; SYNCOPE, VASOVAGAL; TILT-TABLE TEST; VASOCONSTRICTOR AGENTS;

EID: 14844295467     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcp042601     Document Type: Review

References (54)

1. Grubb BP. Neurocardiogenic syncope. In: Grubb B, Olshansky B, eds. Syncope: mechanisms and management. Malden, Mass.: Blackwell/Futura Publishing (in press).
2. Linzer M, Pontinen M, Gold GT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 1991;44: 1037-43.
3. Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. 1. Value of history, physical examination, and electrocardiography: Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997;126:989-96.
4. Goldschlager N, Epstein AE, Grubb BP, et al. Etiologic considerations in the patient with syncope and an apparently normal heart. Arch Intern Med 2003;163:151-62.
5. Grubb BP, Karas B. Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation, and management. Pacing Clin Electrophysiol 1999; 22:798-810.
6. Wieling W, van Lieshout J. Maintenance of postural normotension in humans. In: Low PA, ed. Clinical autonomic disorders: evaluation and management. 2nd ed. Philadelphia: Lippincott-Raven, 1997:73-82.
7. Shepherd RFJ, Shepherd JT. Control of the blood pressure and the circulation in man. In: Mathias CJ, Bannister R, eds. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford, England: Oxford University Press, 1999:72-5.
8. Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation 2000;102:2898-906.
9. Kosinski D, Grubb BP, Temesy-Armos P. Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives. Pacing Clin Electrophysiol 1995;18:716-24.
10. Lurie KG, Benditt D. Syncope and the autonomic nervous system. J Cardiovasc Electrophysiol 1996;7:760-76.
11. Grubb BP, Kosinski D. Tilt table testing: concepts and limitations. Pacing Clin Electrophysiol 1997;20:781-7.
12. Sutton R, Benditt DG. The basic autonomic assessment. In: Benditt DG, Blanc J-J, Brignole M, Sutton R, eds. The evaluation and treatment of syncope: a handbook for clinical practice. Elmsford, N.Y.: Futura, 2003:75-6.
13. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for accessing syncope. J Am Coll Cardiol 1996;28:263-75.
14. Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001;22: 1256-306.
15. Natale A, Akhtar M, Jazayeri M, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 1995;92: 54-8.
16. Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001;104:46-51.
17. Fitzpatrick AP. Ambulatory electrocardiographic (AECG) monitoring for evaluation of syncope. In: Benditt DG, Blanc J-J, Brignole M, Sutton R, eds. The evaluation and treatment of syncope: a handbook for clinical practice. Elmsford, N.Y.: Futura, 2003:63-70.
18. Krediet CT, van Dijk N, Linzer M, van Lieshout JJ, Wieling W. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002;106:1684-9.
19. Brignole M, Croci F, Menozzi C, et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002;40:2053-9.
20. Younoszai AK, Franklin WH, Chan DP, Cassidy SC, Allen HD. Oral fluid therapy: a promising treatment for vasodepressor syncope. Arch Pediatr Adolesc Med 1998; 152:165-8.
21. El-Sayed H, Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 1996;75:134-40.
22. Ector H, Reybrouck T, Heidbuchel H, Gewillig M, Van de Werf F. Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin Electrophysiol 1998;21: 193-6.
23. Foglia G, Giada F, Gaggioli G, et al. Efficacy of tilt training in the treatment of neurally mediated syncope: a randomized study. Europace 2004;6:199-204.
24. Brignole M. Randomized clinical trials of neurally mediated syncope. J Cardiovasc Electrophysiol 2003;14:Suppl:S64-S69.
25. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992;70:339-42.
26. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996;78:536-9.
27. DiGerolamo E, Dilorio C, Sabatiru P, et al. Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope. Cardiologia 1998;43:833-7. (In Italian.)
28. Madrid AH, Ortega J, Rebollo JG, et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001;37: 554-9.
29. Ventura R, Maas R, Zeidler D, et al. A randomized and controlled pilot trial of β-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 2002;25:816-21.
30. Flevari P, Livanis EG, Theodorakis GN, Zarvalis E, Mesiskli T, Kremastinos DT. Vasovagal syncope: a prospective, randomized, cross-over evaluation of the effects of propranolol, nadolol and placebo on syncope recurrence and patients' well-being. J Am Coll Cardiol 2002;40:499-504.
31. Sheldon R. The Prevention of Syncope Trial (POST) results. Presented at Late-breaking Clinical Trials, Heart Rhythm 2004: 25th Annual Scientific Sessions, San Francisco, May 19-22, 2004.
32. Parry SW, Kenny RA. The management of vasovagal syncope. QJM 1999;92:G97-705.
33. Scott WA, Pongiglione G, Bromberg BI, et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 1995;76:400-2.
34. Low PA, Gilden JL, Freeman R, et al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. JAMA 1997; 277:1046-51. [Erratum, JAMA 1997;278: 388.]
35. Low PA, Gilden JL, Freeman R, et al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. JAMA 1997; 277:1046-51. [Erratum, JAMA 1997;278: 388.]
36. Ward CR, Gray JC, Gilroy JJ, Kenny RA. Midodrine: a role in the management of neurocardiogenic syncope. Heart 1998;79: 45-9.
37. Kaufmann H, Saadia D, Voustianiouk A. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 2002;52:342-5.
38. Perez-Lugones A, Schweikert R,Pavia S, et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 2001;12:935-8.
39. Grubb BP, Kosinski D, Mouhaffel A, Pothoulakis A. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. Pacing Clin Electrophysiol 1996;19:836-40.
40. Raviele A, Brignole M, Sutton R, et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial: the Vasovagal Syncope International Study. Circulation 1999;99:1452-7.
41. Kuhn DM, Wolfe WA, Lovenberg W. Review of the central serotonergic neuronal system in blood pressure regulation. Hypertension 1980;2:243-55.
42. Grubb BP, Karas BJ. The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances. J Interv Card Electrophysiol 1998;2:325-32.
43. Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliott L. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt-induced syncope. Pacing Clin Electrophysiol 1993;16:458-64.
44. Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999;33:1227-30.
45. Lee TM, Su SF, Chen MF, Liau CS, Lee YT. Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 1996; 78:480-2.
46. McGrady AV, Arguera Bernal GA. Relaxation-based treatment of stress induced syncope. J Behav Ther Exp Psychiatry 1986;17: 23-7.
47. McGrady AV, Bush EG, Grubb BP. Outcome of biofeedback-assisted relaxation for neurocardiogenic syncope and headache: a clinical replication series. Appl Psychophysiol Biofeedback 1997;22:63-72.
48. Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal Pacemaker Study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16-20.
49. Sutton R, Brignole M, Menozzi C, et al. Dual-chamber pacing in treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation 2000;102:294-9.
50. Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 2001;104:52-7.
51. Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 2003;289:2224-9.
52. Giada F, Raviele A, Menozzi C, et al. The Vasovagal Syncope and Pacing Trial (Synpace): a randomized placebo-controlled study of permanent pacing for treatment of recurrent vasovagal syncope. Pacing Clin Electrophysiol 2003;26:1016. abstract.
53. Sutton R. Has cardiac pacing a role in vasovagal syncope? J Interv Card Electrophysiology 2003;9:145-9.
54. Bloomfield DM, Sheldon R, Grubb BP, Calkins H, Sutton R. Putting it together: a new treatment algorithm for vasovagal syncope and related disorders. Am J Cardiol 1999;84:33Q-39Q.